Jesús
Fortun Abete
Profesor/a Asociado/a en CC. de la Salud
Instituto de Salud Carlos III
Madrid, EspañaInstituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2021
-
Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study)
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 8
-
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)
Mycoses, Vol. 64, Núm. 11, pp. 1334-1345
-
Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015
Emerging Infectious Diseases, Vol. 27, Núm. 1, pp. 26-35
2020
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
-
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia
American Journal of Transplantation, Vol. 20, Núm. 6, pp. 1629-1641
2019
-
Pharmacokinetics of Micafungin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis With High Cutoff Membranes
Therapeutic Drug Monitoring, Vol. 41, Núm. 3, pp. 376-382
2018
-
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Clinical Microbiology and Infection, Vol. 24, pp. e1-e38
-
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)
Clinical Microbiology and Infection, Vol. 24, pp. S53-S70
2017
-
Epidemiology and prognosis of candidaemia in elderly patients
Mycoses, Vol. 60, Núm. 12, pp. 808-817
2016
-
Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations
Transplantation Reviews, Vol. 30, Núm. 3, pp. 119-143